ADPT

Adaptive Biotechnologies Corp

NasdaqGS · Healthcare

$21.80

+8.13% today

last filing 2026-07-02Pro sees filings in ~15 min

Price

hover · 4 moves explained

43 sells

Analyst consensus

Strong Buy

$20.57target-5.6%vs $21.80 today

$19.00 low today target$22.00 high

7 analysts · ~12-month consensus · as of Jul 10. Relayed analyst opinion, which tends to run optimistic — not our forecast or advice.

Earnings

Beat 4 of last 4

Earnings per share · actual vs forecast

Q2 '25+28.6%

−$0.17

exp −$0.24

Q3 '25

$0.06

exp −$0.14

Q4 '25+50.8%

−$0.09

exp −$0.18

Q1 '26+20.2%

−$0.13

exp −$0.16

Type	Date	Insider	Title	Of stake	Shares	Price	Value
Sell	2026-07-07	ROBINS HARLAN SPlanned	Chief Scientific Officer	—Direct	146,889	$22.45	$3.30M
Sell	2026-07-07	ROBINS HARLAN SPlanned	Chief Scientific Officer	—Direct	239,351	$21.74	$5.20M
Sell	2026-07-06	LO FRANCISPlanned	Chief People Officer	—Direct	44,838	$22.59	$1.01M
Exercise	2026-07-06	LO FRANCISPlanned	Chief People Officer	—Direct	12,637	$8.46	$106.9K
Exercise	2026-07-06	LO FRANCISPlanned	Chief People Officer	—Direct	12,600	$12.14	$153.0K

Sell

ROBINS HARLAN S

Chief Scientific Officer · 2026-07-07

$3.30M

146,889 @ $22.45

Sell

ROBINS HARLAN S

Chief Scientific Officer · 2026-07-07

$5.20M

239,351 @ $21.74

Sell

LO FRANCIS

Chief People Officer · 2026-07-06

$1.01M

44,838 @ $22.59

Exercise

LO FRANCIS

Chief People Officer · 2026-07-06

$106.9K

12,637 @ $8.46

Exercise

LO FRANCIS

Chief People Officer · 2026-07-06

$153.0K

12,600 @ $12.14

82 more transactions on ProFull insider transaction history is a Pro feature.

Upgrade →